Hydroxychloroquine for Covid-19 treatment: Heavy push back despite positive results

Justice Department Sues Monopolist Google For Violating Antitrust Laws

Today, the Department of Justice — along with eleven state Attorneys General — filed a civil antitrust lawsuit in the U.S. District Court for...

U.S. CTO Kratsios named acting undersecretary for research and engineering, Lewis to serve as acting deputy

WASHINGTON — U.S Chief Technology Officer Michael Kratsios will serve as acting undersecretary of defense for research and engineering, DoD announced on July 13. Kratsios...

Poll: 62% of Americans Say They Have Political Views They’re Afraid to Share

Sixty-two percent (62%) of Americans agreed, up from 58% in 2017, leading Cato to conclude that “self‐​censorship is on the rise in the United States.” Republicans were...

The Kate Awakening

Watch Kate Awakening's Videos

Biden Campaign Refuses To Release Cognitive Test Results

Its been three days now since former Vice President Joe Biden told reporters that he’s been “tested and am constantly tested” for cognitive decline....

The growing push-back against the use of Hydroxychloroquine for Covid-19 treatment continues to grow as Ohio’s Board of Pharmacy joins the latest onslaught against hydroxychloroquine (HCQ) as a prophylactic. On July 29th Ohio’s Board of Pharmacy updated it’s rule regarding the potentially life saving drug Hydroxychloroquine. Effective July 30, 2020, BOP rule 4729:5-5-21 of the Administrative Code goes into effect. In general, the rule prohibits the use of hydroxychloroquine and chloroquine for the treatment or prevention of COVID-19. There are some exceptions: Paragraph “C” of the updated rule states: “this rule does not apply to prescriptions issued as part of a documented institutional review board-approved clinical trial to evaluate the safety and efficacy of the drugs to treat COVID-19.Prescriptions must include documentation that the patient is enrolled in a clinical trial. “

The Ohio Board of Pharmacy also cites the FDA’s caution against use of hydroxychloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. But that it does not apply to FDA-approved uses for malaria, lupus, and rheumatoid arthritis; which has many people scratching their heads as to why the double standard of this potential life saving drug that has been safely used for over 6 decades exists.

A new update on the ruling comes a day after America’s Frontline Doctors held a two-day summit on Capitol Hill Monday, July 27th. Dr. Stella Immanuel, a primary care doctor at Rehoboth Medical Center in Houston, Texas, said during the summit that she has treated more than 350 patients with COVID-19 by using a combination of hydroxychloroquine, zinc, and azithromycin, and characterized the combination of drugs as a “cure.” Videos of the doctors have since been removed from Twitter, Facebook, and YouTube among other sites on the night of July 27. Twitter representatives charged that the video contains “misinformation”.

In early July, treatment with Hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 (without heart-related side-effects). Conducted in Detroit Michigan, the study published by Henry Ford Health System showed that out of 2,541 patients, 460 died but the median age was 64 (53 –76) years old. According to data published by the Center of Disease Control, 8 out of 10 Covid-19 Deaths have been with adults 65 years and older. There is also substantial research regarding HCQ’s ability to be used as a preventative medication in addition to it being a primary treatment to those infected with COVID.

President Donald Trump has been reported to have taken hydroxychloroquine for two weeks earlier this year as a preventive measure. He told reporters that his own experience with the drug was positive, saying, “it’s safe. It doesn’t cause problems. I had no problem.” A study conducted in France showed the combination of hydroxychloroquine (HCQ) and azithromycin (AZ) used in the treatment of COVID-19 resulted in a good clinical outcome. Virological cure was obtained in 973 patients within 10 days (91.7%). Prolonged viral carriage was observed in 47 patients (4.4%) and negative by day 10.

With a continuous stream of positive pharmaceutical testing and a clear ability to save lives, many are beginning to ask themselves: “then why is this drug and information about it being censored by big tech and the MSM?” This is due to their well known status of being an “enemy of the people.” This censorship is not just about the virus, it is about trying to prolong the virus and its far-reaching effects on society. The election is in November; if they are able to prolong the hysteria and continue to shut down large gatherings, their attempts to hijack the results of the 2020 Election will have a much greater chance of success.


Comments are closed.

Hot Topics

Hollywood Producer Who Was Part Of Jeffrey Epstein’s “Lolita Express Circle” Dead – Falls Off 27th Floor Of Building

I’m sure this is just a coincidence, right? Just prior to the arrest of Ghislaine Maxwell this week, Hollywood producer and long time friend...

Federal Judge Rejects Additional Discovery in Case Concerning Hillary Clinton’s Emails

A federal judge in Washington, D.C. on Friday denied a request for additional discovery in a lawsuit concerning Hillary Clinton's use of a private...

RedRacer Video

Watch Tito Ortiz's Videos

Related Articles

Over 432,000 Votes Removed From Trump in Pennsylvania, Data Scientists Say

Pennsylvania election data shows that over 432,000 votes were removed from President Donald Trump during the November election, data scientists say. According to an analysis by...

Dem Rep. ends congressional prayer with ‘Amen and awomen’

Rep. Emanuel Cleaver, D-MO, opened the 117th Congress with a prayer that ended with an attempt to bring in more gender-inclusive language. The Democratic lawmaker,...

Pentagon orders USS Nimitz to stay in Persian Gulf after Iranian threats against Trump

The Pentagon on Sunday evening order the USS Nimitz to remain in the Persian Gulf, reversing a planned redeployment, after Iran made threats against...